奥世美
很好用的app，专门为奥世美设计的
MaxOrth
Published by:
Shenzhen Becoming Medical E-CommerceLtd
Description
MaxOrth奥世美数字正畸交互平台是一款专为奥世美医生开发的移动端病例管理APP。
对于已有账号的用户可直接下载安装，登录后即可同步牙e云信息。
全新上线的MaxOrth奥世美数字正畸交互平台具有五大亮点：
1-病例管理功能：用户可在APP内对全系列产品进行病例状态查询，3D方案查看、审核、建议提交等，也可预知方案出具日期和产品发货时间，使用更加便捷、友好、随心；
2-医患沟通功能：方案出具后用户可通过3D界面的“一键转发”按钮分享至微信，让医患沟通更加直观、灵活；
3-货件追踪功能：登录APP后查看已发货产品实时物流信息，以便及时跟进；
4-医助协同功能：角色为“医生”的用户可在账号中绑定机构归属地相同的“医助”账号，并对其开放相应的权限，协助医生完成病例协同；
5-产品售后功能：为已出货的病例提供产品售后功能。
MaxOrth奥世美数字正畸交互平台仍在不断拓展完善，后续更新敬请期待！
Hide
Show More...
对于已有账号的用户可直接下载安装，登录后即可同步牙e云信息。
全新上线的MaxOrth奥世美数字正畸交互平台具有五大亮点：
1-病例管理功能：用户可在APP内对全系列产品进行病例状态查询，3D方案查看、审核、建议提交等，也可预知方案出具日期和产品发货时间，使用更加便捷、友好、随心；
2-医患沟通功能：方案出具后用户可通过3D界面的“一键转发”按钮分享至微信，让医患沟通更加直观、灵活；
3-货件追踪功能：登录APP后查看已发货产品实时物流信息，以便及时跟进；
4-医助协同功能：角色为“医生”的用户可在账号中绑定机构归属地相同的“医助”账号，并对其开放相应的权限，协助医生完成病例协同；
5-产品售后功能：为已出货的病例提供产品售后功能。
MaxOrth奥世美数字正畸交互平台仍在不断拓展完善，后续更新敬请期待！
Screenshots
MaxOrth FAQ
-
Is MaxOrth free?
Yes, MaxOrth is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is MaxOrth legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does MaxOrth cost?
MaxOrth is free.
-
What is MaxOrth revenue?
To get estimated revenue of MaxOrth app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Brazil yet.
Ratings History
MaxOrth Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
MaxOrth Installs
Last 30 days
MaxOrth Revenue
Last 30 daysMaxOrth Revenue and Downloads
Gain valuable insights into MaxOrth performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Utilities
- Publisher
- Shenzhen Becoming Medical E-CommerceLtd
- Languages
- English, Chinese
- Recent release
- 1.2.1 (3 weeks ago )
- Released on
- Sep 29, 2022 (2 years ago )
- Also available in
- China , Poland , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Norway , Peru , Philippines , Pakistan , Italy , Portugal , Russia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , Algeria , Argentina , Austria , Australia , Azerbaijan , Brazil , Belarus , Canada , Switzerland , Chile , Czechia , Denmark , Japan , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Israel , India , United Arab Emirates
- Last Updated
- 2 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.